Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology
Journal of Obstetrics and Gynaecology Research · 2026-04 · 52 (4)
DOI: 10.1111/jog.70277 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 13.04.2026. Verfasst von Gunvanti Rathod und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, AIIMS, Bibinagar, Telangana, India. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Pathology Department, AIIMS, Bibinagar, Telangana, India.
- FMT Department, AIIMS, Bibinagar, Telangana, India.
ORCID-Profile: Gunvanti Rathod, Pragnesh Parmar
Zitieren
APA
Rathod, G., & Parmar, P. (2026). Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology. Journal of Obstetrics and Gynaecology Research, 52(4). https://doi.org/10.1111/jog.70277
Vancouver
Rathod G, Parmar P. Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology. Journal of Obstetrics and Gynaecology Research. 2026;52(4). doi:10.1111/jog.70277
BibTeX
@article{Rathod2026,
author = {Rathod, Gunvanti and Parmar, Pragnesh},
title = {Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
volume = {52},
number = {4},
doi = {10.1111/jog.70277}
}
EUVIMED